A Case of Acquired Hemophilia A in a Patient with Exposure to COVID-19

Acquired Hemophilia A (AHA) is a very rare autoimmune condition involving immune-mediated depletion of Factor VIII, resulting in spontaneous hemorrhage. Failure to recognize AHA as a possible etiology of hemorrhage can result in delayed diagnosis and treatment. The COVID-19 pandemic has given rise t...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in hematology 2022-03, Vol.2022, p.9494249-3
Main Authors: Guerra, Jorge D., Gowarty, Jasmine, Buess, Jordan, Mason, James, Halka, Kathleen
Format: Article
Language:English
Subjects:
Anemia
Blood coagulation factor VIII
Blood coagulation factors
Blood diseases
Case Report
Case reports
Coronaviruses
COVID-19
Development and progression
Epstein-Barr virus
Health aspects
Hematology
Hematuria
Hemoglobin
Hemophilia
Hemorrhage
Infections
Patients
Pneumonia
Purpura
Remission (Medicine)
Severe acute respiratory syndrome coronavirus 2
Urology
Viral infections
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Acquired Hemophilia A (AHA) is a very rare autoimmune condition involving immune-mediated depletion of Factor VIII, resulting in spontaneous hemorrhage. Failure to recognize AHA as a possible etiology of hemorrhage can result in delayed diagnosis and treatment. The COVID-19 pandemic has given rise to several hematologic conditions and complications, with a rare manifestation being Acquired Hemophilia A (AHA). An interesting case of AHA following SARS-CoV-2 infection is described, along with the treatment approach and a brief review of several cases describing AHA in association with COVID-19.
ISSN:2090-6560
2090-6579
DOI:10.1155/2022/9494249